Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLSCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PNMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXP4-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FGD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZYG11B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SORL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS6KA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTYMK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506098 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on